Researchers are advancing a revolutionary approach to treating autoimmune diseases such as rheumatoid arthritis, multiple sclerosis, and lupus by reprogramming patients' immune systems.Dr. Maximilian Konig, a rheumatologist at Johns Hopkins University, emphasizes the potential of these new methods to significantly transform disease management.Patients like Mileydy Gonzalez have reported substantial improvements after participating in CAR-T therapy trials, experiencing relief from lupus pain that had plagued them for years.